{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:06:27Z","timestamp":1753887987152,"version":"3.41.2"},"reference-count":46,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ABCD, arq. bras. cir. dig."],"abstract":"<jats:p>ABSTRACT  BACKGROUND: Anal cancer is a relatively rare disease, and there is a lack of survival data from low- and middle-income countries.  AIMS: The aim of this study was to investigate the survival rates and prognostic factors of anal cancer cases treated at a High-Complexity Oncology Care Center in Rio de Janeiro, Brazil.  METHODS: A retrospective cohort study was conducted involving 665 cases of squamous cell carcinoma of the anus\/anal canal treated from 2000 to 2016. To estimate the 5-year overall survival probability and survival according to selected variables, the Kaplan-Meier method and the log-rank test were applied. To identify factors associated with survival, the Cox proportional hazards model, stratified by staging, was used to estimate hazard ratios (HR). Ninety-five percent confidence intervals (95%CI) were also calculated.  RESULTS: The overall survival probability was 62.20% (95%CI 57.90\u201366.20). Higher survival rates were observed in female cases, those with non-advanced staging, and those treated with chemoradiotherapy (p&lt;0.001). Among cases with advanced staging, being female was a protective factor against death (HR=0.52; 95%CI 0.28\u20130.93). Compared to chemoradiotherapy, at least one type of treatment was identified as a risk factor: chemoradiotherapy + surgery among cases with non-advanced staging (HR=22.65; 95%CI 5.65\u201390.81), radiotherapy among cases with advanced staging (HR=2.71; 95%CI 1.39\u20135.30), and among cases with unknown staging, no treatment (HR=3.36; 95%CI 1.73\u20136.50), radiotherapy (HR=2.38; 95%CI 1.46\u20133.88), and radiotherapy + surgery (HR=3.99; 95%CI 1.20\u201313.27).  CONCLUSIONS: The findings support the superiority of chemoradiotherapy over other therapeutic modalities for anal cancer, resulting in increased survival and a better prognosis.<\/jats:p>","DOI":"10.1590\/0102-6720202400037e1830","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T11:30:29Z","timestamp":1730115029000},"source":"Crossref","is-referenced-by-count":0,"title":["SURVIVAL AND PROGNOSTIC FACTORS OF ANAL CANCER: A STUDY BASED ON DATA FROM THE HOSPITAL-BASED CANCER REGISTRY OF A HIGH-COMPLEXITY ONCOLOGY CARE CENTER"],"prefix":"10.1590","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2533-4707","authenticated-orcid":false,"given":"Wallace Henrique Pinho da","family":"PAIX\u00c3O","sequence":"first","affiliation":[{"name":"Instituto Nacional de C\u00e2ncer,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9564-0892","authenticated-orcid":false,"given":"Gelcio Luiz Quintella","family":"MENDES","sequence":"additional","affiliation":[{"name":"Instituto Nacional de C\u00e2ncer,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1746-4544","authenticated-orcid":false,"given":"D\u00e9bora Santos da","family":"SILVA","sequence":"additional","affiliation":[{"name":"Instituto Nacional de C\u00e2ncer,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5934-1567","authenticated-orcid":false,"given":"Rosyane Garc\u00eas Moreira Lima de","family":"SOUZA","sequence":"additional","affiliation":[{"name":"Instituto Nacional de C\u00e2ncer,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0033-2545","authenticated-orcid":false,"given":"Rodrigo Otavio de Castro","family":"ARAUJO","sequence":"additional","affiliation":[{"name":"Instituto Nacional de C\u00e2ncer,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1722-5703","authenticated-orcid":false,"given":"Karina Cardoso","family":"MEIRA","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Norte,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-7138","authenticated-orcid":false,"given":"Rafael Tavares","family":"JOMAR","sequence":"additional","affiliation":[{"name":"Instituto Nacional de C\u00e2ncer,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"issue":"16","key":"ref1","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","article-title":"Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial","volume":"299","author":"Ajani JA","year":"2008","journal-title":"JAMA"},{"issue":"4","key":"ref2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/DCR.0b013e31819eb7f0","article-title":"Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base","volume":"52","author":"Bilimoria KY","year":"2009","journal-title":"Dis Colon Rectum"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/CEJ.0000000000000163","article-title":"Trends of incidence and survival in squamous-cell carcinoma of the anal canal in France: a population-based study","volume":"25","author":"Bouvier AM","year":"2016","journal-title":"Eur J Cancer Prev"},{"series-title":"Departamento de HIV\/AIDS, Tuberculoses, Hepatites Virais e Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis. Usar preservaticos masculinos, femininos e gel lubrificantes","key":"ref4"},{"series-title":"HPV","key":"ref5"},{"issue":"3","key":"ref6","first-page":"579","article-title":"Survival analysis techniques","volume":"18","author":"Bustamante-Teixeira MT","year":"2002","journal-title":"Cad Saude Publica"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/jamasurg.2017.3151","article-title":"Management of stage I squamous cell carcinoma of the anal canal","volume":"153","author":"Chai CY","year":"2018","journal-title":"JAMA Surg"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ijc.33185","article-title":"A meta-analysis of anal cancer incidence by risk group: toward a unified anal cancer risk scale","volume":"148","author":"Clifford GM","year":"2021","journal-title":"Int J Cancer"},{"issue":"09","key":"ref9","first-page":"4021","article-title":"Gender and racial inequalities in the access to and the use of Brazilian health services","volume":"26","author":"Cobo B","year":"2021","journal-title":"Cienc Sa\u00fade Colet"},{"issue":"8","key":"ref10","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/jnci\/djz219","article-title":"Recent trends in squamous cell carcinoma of the anus incidence and mortality in the United States, 2001-2015","volume":"112","author":"Deshmukh AA","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.ijrobp.2004.07.687","article-title":"Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness","volume":"61","author":"Ferrigno R","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1470-2045(05)70471-X","article-title":"Survival from rare cancer in adults: a population-based study","volume":"7","author":"Gatta G","year":"2006","journal-title":"Lancet Oncol"},{"issue":"8","key":"ref13","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.3748\/wjg.v21.i8.2294","article-title":"Anal cancer treatment: current status and future perspectives","volume":"21","author":"Ghosn M","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/j.clcc.2018.10.001","article-title":"Rising Incidence and improved survival of anal squamous cell carcinoma in Norway, 1987-2016","volume":"18","author":"Guren MG","year":"2019","journal-title":"Clin Colorectal Cancer"},{"year":"2010","series-title":"Registros hospitalares de c\u00e2ncer: planejamento e gest\u00e3o","key":"ref15"},{"series-title":"Atlas on-line de mortalidade","key":"ref16"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.annepidem.2013.07.021","article-title":"Quantifying lead-time bias in risk factor studies of cancer through simulation","volume":"23","author":"Jansen RJ","year":"2013","journal-title":"Ann Epidemiol"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1016\/j.vaccine.2011.01.015","article-title":"Trends in anal cancer in Australia, 1982-2005","volume":"29","author":"Jin F","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cncr.20364","article-title":"Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000","volume":"101","author":"Johnson LG","year":"2004","journal-title":"Cancer"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal","volume":"86","author":"Kachnic LA","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e1729","DOI":"10.1590\/0102-672020230002e1729","article-title":"Colorectal cancer: association between sociodemographic variables and the adherence to cancer screening","volume":"36","author":"Kupper BEC","year":"2023","journal-title":"Arq Bras Cir Dig"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4097\/kjae.2017.70.4.407","article-title":"Statistical data preparation: management of missing values and outliers","volume":"70","author":"Kwak SK","year":"2017","journal-title":"Korean J Anesthesiol"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1245\/s10434-019-07202-4","article-title":"Survival outcomes and patterns of management for anal adenocarcinoma","volume":"26","author":"Lewis GD","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"ref24","first-page":"6018269","article-title":"Human papillomavirus and anal cancer: prevalence, genotype distribution, and prognosis aspects from Midwestern Region of Brazil","volume":"2019","author":"Libera LSD","year":"2019","journal-title":"J Oncol"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1473-3099(17)30653-9","article-title":"Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis","volume":"18","author":"Lin C","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/emj.20.1.54","article-title":"Observational research methods. Research design II: cohort, cross sectional, and case-control studies","volume":"20","author":"Mann CJ","year":"2003","journal-title":"Emerg Med J"},{"series-title":"Surveillance, Epidemiology, and End Results. cancer stat facts: anal cancer","key":"ref27"},{"series-title":"Cancer survival in England, cancers diagnosed 2015 to 2019, followed up to 2020","key":"ref28"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/1097-0142(19830515)51:10<1826::AID-CNCR2820511012>3.0.CO;2-L","article-title":"Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal","volume":"51","author":"Nigro ND","year":"1983","journal-title":"Cancer"},{"issue":"3","key":"ref30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF02586980","article-title":"Combined therapy for cancer of the anal canal: a preliminary report","volume":"17","author":"Nigro ND","year":"1974","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"ref31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3393\/ac.2020.12.29","article-title":"Survival and operative outcomes after salvage surgery for recurrent or persistente anal cancer","volume":"36","author":"Park IJ","year":"2020","journal-title":"Ann Coloproctol"},{"issue":"2","key":"ref32","first-page":"119","article-title":"Retrospective analysis of patients with anal tumors diagnosed at the School of Medicine of Ribeir\u00e3o Preto Hospital and Clinics (HC-FMRP), between 1979 and 2004 and literature review","volume":"27","author":"Parra RS","year":"2007","journal-title":"Rev Bras Colo-Proctol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.amsu.2020.04.016","article-title":"Squamous cell anal cancer: management and therapeutic options","volume":"55","author":"Pessia B","year":"2020","journal-title":"Ann Med Surg (Lond)"},{"issue":"4","key":"ref34","first-page":"e1637","article-title":"HPV16 and expression of protein P16INK4A and E7 oncoprotein in colorectal carcinoma","volume":"34","author":"Pican\u00e7o Junior OM","year":"2022","journal-title":"Arq Bras Cir Dig"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.annonc.2021.06.015","article-title":"Anal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Rao S","year":"2021","journal-title":"Ann Oncol"},{"key":"ref36","series-title":"Anal cancer","first-page":"11","volume-title":"Epidemiology and pathogenesis of anal cancer. In:","author":"Roveda JD","year":"2019"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"e-213700","DOI":"10.32635\/2176-9745.RBC.2023v69n1.3700","article-title":"Estimated cancer incidence in Brazil, 2023-2025","volume":"69","author":"Santos MO","year":"2023","journal-title":"Rev Bras Cancerol"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"djv086","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines","volume":"107","author":"Saraiya M","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"ref39","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/bjc.2016.304","article-title":"Cancer incidence and mortality projections in the UK until 2035","volume":"115","author":"Smittenaar CR","year":"2016","journal-title":"Br J Cancer"},{"issue":"6","key":"ref40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.canep.2015.10.008","article-title":"Trends in incidence and survival for anal cancer in New South Wales, Australia, 1972-2009","volume":"39","author":"Soeberg MJ","year":"2015","journal-title":"Cancer Epidemiol"},{"issue":"suppl 1","key":"ref41","first-page":"2529","article-title":"Health insurance coverage in Brazil: analyzing data from the National Health Survey, 2013 and 2019","volume":"26","author":"Souza J\u00fanior PRB","year":"2021","journal-title":"Cien Saude Colet"},{"key":"ref42","series-title":"Anal cancer","first-page":"1","volume-title":"Anatomy and histology of the anus. In:","author":"Sundel MH","year":"2019"},{"issue":"3","key":"ref43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"ref44","article-title":"Brazilian Society of Surgical Oncology: guidelines for the management of anal canal cancer","author":"Valad\u00e3o M","year":"2023","journal-title":"J Surg Oncol"},{"year":"2012","series-title":"CID-10: Classifica\u00e7\u00e3o estat\u00edstica internacional de doen\u00e7as e problemas relacionados \u00e0 sa\u00fade","key":"ref45"},{"year":"2013","series-title":"CID-O: Classifica\u00e7\u00e3o internacional de doen\u00e7as para oncologia","key":"ref46"}],"container-title":["ABCD. Arquivos Brasileiros de Cirurgia Digestiva (S\u00e3o Paulo)"],"original-title":["SOBREVIDA E FATORES PROGN\u00d3STICOS DO C\u00c2NCER ANAL: ESTUDO BASEADO EM DADOS DO REGISTRO HOSPITALAR DE C\u00c2NCER DE UM CENTRO DE ALTA COMPLEXIDADE EM ONCOLOGIA"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0102-67202024000100321&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T11:30:46Z","timestamp":1730115046000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0102-67202024000100321&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":46,"alternative-id":["S0102-67202024000100321"],"URL":"https:\/\/doi.org\/10.1590\/0102-6720202400037e1830","relation":{},"ISSN":["2317-6326","0102-6720"],"issn-type":[{"type":"electronic","value":"2317-6326"},{"type":"print","value":"0102-6720"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e1830"}}